scispace - formally typeset
K

Ken Kawamoto

Researcher at University of California, San Francisco

Publications -  38
Citations -  2877

Ken Kawamoto is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: DNA methylation & Genotype. The author has an hindex of 27, co-authored 38 publications receiving 2800 citations. Previous affiliations of Ken Kawamoto include San Francisco VA Medical Center & University of California.

Papers
More filters
Journal ArticleDOI

Identification of novel microRNA targets based on microRNA signatures in bladder cancer.

TL;DR: The target search algorithm and gene‐expression profiling in BCs revealed that Keratin7 (KRT7) mRNA was a common target of the downregulated miRNAs, and the mRNA expression levels of KRT7 were significantly higher inBCs than in NBEs.
Journal ArticleDOI

Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.

TL;DR: The above article, published online on 22 April 2008 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, Prof. Peter Lichter, and John Wiley & Sons Ltd.
Journal ArticleDOI

Genistein Induces the p21WAF1/CIP1 and p16INK4a Tumor Suppressor Genes in Prostate Cancer Cells by Epigenetic Mechanisms Involving Active Chromatin Modification

TL;DR: The data provide new insights into the epigenetic mechanism of the action of genistein that may contribute to the chemopreventive activity of this dietary isoflavone and have important implications for epigenetic therapy.
Journal ArticleDOI

Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity.

TL;DR: The findings suggest that aberrant AEG-1 expression plays a dominant role as a positive auto-feedback activator of AKT and as a suppressor of FOXO3a in PC cells, and may represent a novel genetic biomarker to serve as an attractive molecular target for new anticancer agents to prevent PC cell progression and metastasis.
Journal ArticleDOI

Combination Analysis of Hypermethylated Wnt-Antagonist Family Genes as a Novel Epigenetic Biomarker Panel for Bladder Cancer Detection

TL;DR: This is the first report demonstrating that M score analysis of Wnt-antagonist genes could serve as an excellent epigenetic biomarker panel for bladder tumors.